T. denticola antigens is practically absent from the literature. To date only TdpA, an otherwise uncharacterized putative lipoprotein, has been reported to be reactive in serum from periodontitis subjects. However this report was based on a single uncontrolled experiment using a recombinant TdpA protein (22) . No studies have reported expression of Msp or the protease complex in human subjects. For this reason, we chose to focus on the identification of specific T. denticola protein antigens recognized by serum antibodies from human subjects.
The role of humoral immune responses to T. denticola in progression or resolution of disease is not well understood. The results of several studies of serum responses to oral spirochetes in periodontal disease [reviewed in (9) ] suggest that significant exposure to oral treponemes may result in a non-productive or suppressed immune response. More recently, Kesavalu et al. reported that humoral immune responses, as manifested by antibody levels, isotype, and antigenic specificity, were not capable of resolving T. denticola infection in a mouse infection model (17) . This pattern is not unlike what is seen in other spirochete pathogens, including Treponema pallidum and Borrelia burgdorferi, both of which cause chronic infection mediated by one or more mechanisms of immune evasion or suppression. In the case of both of these organisms, there has been considerable controversy as to the identity of cell surface proteins expressed during infection and their roles in disease (7, 25) .
Our laboratory has developed a series of defined isogenic T. denticola mutants defective in one or more components of Msp and the PrtP protease complex (4, 12, 18) . To characterize the immunogenicity of these outer membrane components, we used human serum samples to probe T. denticola ATCC 35405 parent and isogenic mutant strains as well as T. denticola and Escherichia coli strains expressing different Msp types. Here we present definitive evidence that Msp and the proteins comprising the PrtP complex are expressed in the human host. Furthermore, we demonstrate that anti-Msp human antibodies can show strain specificity consistent with serogrouping of T. denticola strains.
Materials and methods

Human serum samples
Archived adult serum samples were used in this study. Initial characterization of these samples has been described in previous studies (2, 20) . Subjects whose sera were used were classified as having moderate to severe gingivitis, but exhibited little evidence of destructive periodontal disease. Use of these samples was conducted under protocols approved by the University of Michigan Health Sciences Institutional Review Board.
Bacterial growth and sample preparation
The T. denticola strains used in this study (listed in Table 1 ) were grown anaerobically in new oral spirochete (NOS) medium , with erythromycin (40 lg/ml) added as appropriate (12) . Three-day exponential phase cultures were harvested by centrifugation (1200 g, 10 min, 4°C). All further manipulations were carried out at 4°C. Cell pellets were washed twice with phosphate-buffered saline (PBS) containing 1 mm phenylmethylsulfonyl fluoride (PMSF) to inactivate proteases. To ensure equivalent loading of samples, pellets were resuspended in 300-500 ll lysis buffer (1% nonidet P-40, 20 mm HEPES pH 7.4, 250 mm NaCl, 10 mm NaF, 1 mm Na 4 P 2 O 7 , 3 mm ethylenediaminetetraacetic acid, 1 mm PMSF, 1 mm Na 3 VO 4 , 2 mm dithiothreitol, 0.27 m sucrose, 1 mm pNPP, and Roche complete protease inhibitor cocktail in 10 ml) based on optical density of the culture, and mixed until translucent. Extracts consisting of total cell lysates were clarified by centrifugation (16,000 g, 20 min). Soluble supernatants containing proteins from equivalent numbers of cells per ll were collected, heated at 100°C for 5 min, divided into aliquots and stored at )80°C until use.
E. coli strains were grown in LuriaBertani (LB) broth or agar with ampicillin (50 lg/ml), carbenicillin (50 lg/ml) or chloramphenicol (34 lg/ml), as appropriate. DNA encoding the mature Msp peptides of T. denticola 35405, 33520 and OTK (13) was amplified from genomic DNA by polymerase chain reaction and cloned into E. coli plasmid vector pET17b (Novagen, Madison, WI), as described previously (11) . For expression of recombinant Msp, the resulting plasmids (or empty vector) were introduced into E. coli Rosetta TM (DE3)pLysS (Novagen). Expression of Msp was induced as described previously (11), and cultures were harvested after 3 h. Cell pellets were rinsed once in PBS, recentrifuged, and resuspended in PBS to a standardized optical density and lysed in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer. After heating at 100°C for 5 min, sample aliquots were stored at )80°C until use.
SDS-PAGE and Western blots
Protein extract aliquots were thawed on ice, mixed with sample buffer, boiled for 7 min and subjected to 4-20% SDS-PAGE. Proteins in gels were stained with Coomassie brilliant blue or transferred to nitrocellulose membranes at 25 V for 1 h. Membranes were stained with Ponceau-S to verify protein transfer, blocked for at least 1 h (5% non-fat milk, 0.2% Tween-20 in Tris-buffered saline), and probed with human sera (dilution 1 : 500) or anti-T•7Tag monoclonal antibody (Novagen, #69522; dilution 1 : 10,000) in blocking solution for a minimum of 2 h. Membranes were rinsed three times with TBS-0.2% Tween-20 for 10 min at room temperature and incubated with peroxidase-conjugated goat anti-human immunoglobulin G (IgG; Jackson ImmunoResearch, West Grove, PA, #109-035-088) or peroxidase-conjugated goat anti-mouse IgG (Pierce, Rockford, IL, #31430), as appropriate. Western blots were developed using a chemiluminescent substrate. The secondary antibodies did not recognize T. denticola antigens (data not shown). Archived human sera from a previous study (20) were used to probe the T. denticola 35405 parent and isogenic mutant strains. Fig. 1 shows a representative Western blot in which human IgGs recognized multiple bands in T. denticola 35405. As in other spirochete pathogens, the prominent antigenic band at approximately 43-kDa was most likely flagellin (23, 29) . Comparison with isogenic T. denticola mutants demonstrated that the 53-kDa band was Msp (11) , and that the 72-, 40-, and 30-kDa bands were PrtP, PrcA2, and PrcA1, respectively (18) . The 53-kDa Msp band was absent in the msp mutant MHE. In protease locus mutant P0760, bands corresponding to PrtP, PrcA1, and PrcA2 were absent. Consistent with our previous characterization of this and other protease locus mutants, Msp was also absent from P0760 (4, 12, 18) . This definitive evidence that Msp and the protease complex proteins were expressed and were immunogenic in humans supports their identification as likely virulence determinants. Mechanism(s) involved in inter-related expression of Msp and the protease complex are currently under investigation in our laboratory.
Human serum antibodies recognize specific Msp types T. denticola strains contain a single msp gene, and Msp polypeptides fall into one of three broad groups as defined by DNA sequence and predicted antigenic domains (13) . Strains 35405, 33520, and OTK represent three distinct T. denticola serotypes (5, 13). As shown in Fig. 2A Fig. 2A , we used the same sera to probe extracts of E. coli strains expressing recombinant Msp fused to a vector-encoded T7Tag (Novagen). As shown in Fig. 2B , the sera showed the same pattern of specificity for individual Msp, with the exception that serum 323 reacted less strongly with recombinant OTK T7-Msp than with the native protein.
These results are in agreement with our previous finding that Msp sequences from numerous isolates have considerable amino acid differences in predicted surfaceexposed domains ( (13) and data not shown). Taken together, these data show that Msp is strongly immunogenic in humans, and that T. denticola serotypes are at least partially defined by their Msp type.
Discussion
Previous studies reported that conspicuous differences in anti-T. denticola IgG titers exist between periodontally diseased and healthy subjects [reviewed in (9)]. Serum antibody titers to periodontal pathogens were reduced during the maintenance phase following periodontal therapy (1). However, other studies reported that, despite successful periodontal therapy, anti-T. denticola titers remained elevated over a 30-month period, suggesting that serology may mark the history of past periodontal infection but that it is not indicative of current colonization (24) . Some of the sera used in the present study were from subjects classified as having at most low levels of T. denticola, as measured by reactivity of a subgingival plaque sample with rabbit antibodies raised against T. denticola ATCC 35404 (20) . Interestingly, some of these sera reacted strongly with Msp of one or more T. denticola strains. It cannot be determined from the available reagents whether these subjects had a previous T. denticola infection, or whether the immunological reagents used to detect colonization in the previous study were overly strain-specific (20) . Some serum samples did not react with Msp of the three strains tested (data not shown). Because human serum recognition of Msp can be both strong and strainspecific, previously reported colonization data may be somewhat less than reliable. Our data strongly suggest that the utility of immunological methods to detect or quantify T. denticola and total spirochetes in clinical samples is limited not only by the diversity of oral Treponema species, but also by major antigenic differences between T. denticola strains. Our data demonstrate that Msp is one of the predominant T. denticola antigens recognized by human serum antibodies. Interstrain differences in Msp appear to be a defining element of strain serotype because each wild-type strain tested has a distinct Msp and represents a different serotype. This is consistent with our previous report that rabbit polyclonal antibodies raised against the Msp of strain 35405 did not recognize the Msp of 33520 and OTK (13). Barron et al. reported that T. denticola is the first spirochete to colonize the oral cavity and that T. denticola comprises a major proportion of all spirochetes at all ages tested (3). Furthermore, that study found at least two distinct serotypes of T. denticola in plaque from most children tested. Our results are consistent with this previous finding, with some subjects having serum reactivity to only one T. denticola Msp type, while others recognize two or more Msp types. It should be noted that our study does not address colonization by or immune responses to oral Treponema species other than T. denticola, which probably further complicates the overall picture. The question as to whether antiMsp antibodies are protective against subsequent infection remains to be addressed.
Isogenic mutants of T. denticola are becoming important tools for characterizing host immune responses in periodontal disease. We provide here the first definitive evidence that Msp is a major immunoreactive protein and that the immunogenicity is often strain specific. We also demonstrate that the proteins comprising the PrtP protease complex are immunogenic. This protease complex (CTLP, dentilisin) is present in the three T. denticola serotypes tested as well as in several other species of oral spirochetes (6). While we cannot rule out the possibility that antibody responses to these proteins result from cross-reactivity with other bacterial or human proteins, this is highly unlikely because Msp-like proteins are found only in spirochetes. While PrtP contains conserved peptidase domains, the polypeptides of the protease complex are otherwise unique to oral Treponema species. As shown by their ability to elicit humoral immune responses in humans, our data provide the first evidence that these putative virulence determinants are in fact expressed in vivo. Validation of this key prerequisite for definition as virulence determinants lends strong support to work underway in several laboratories characterizing the role of these surface proteins in the interactions between T. denticola and host immune response pathways.
